Are you comfortable discussing the benefits and risks of screening?
Prostate cancer is the most commonly diagnosed cancer in Nevada (excluding non-melanoma skin cancers), and is the #2 cancer killer among men.
Despite the prevalence of this cancer, research has not yet proven if the potential benefits of prostate cancer screening outweigh the limitations of the testing and treatment. Most major health organiztions recommend health care providers discuss screening with their patients to help them make an informed decision about whether to be tested for prostate cancer.
It is recommended to begin this conversation with male patients when they reach 50. For those men at higher risk, including African Americans or men who have a father or brother diagnosed with prostate cancer before age 65, a discussion should begin at age 45.
The current US Preventive Services Task Force guidelines for prostate cancer screening are under review. Review the draft recommendation here.
Materials and Resources
|"Is Prostate Cancer Screening Right for You" Decision Aid for Patients, USPSTF April 2017||Download PDF|